The new face of nucleolin in human melanoma

Cancer Immunology, Immunotherapy

Volumn 58, Issue 9, 2009, Pages 1471-1480

  Hoja ŁUkowicz, Dorota ^a   Przybyło, Małgorzata ^a   Pocheć, Ewa ^a   Drabik, Anna ^a   Silberring, Jerzy ^a   Kremser, Marcelina ^a   Schadendorf, Dirk ^b   Laidler, Piotr ^a   Lityńska, Anna ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Melanoma; Nucleolin; Tn antigen

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NUCLEOLIN; TN ANTIGEN; TUMOR MARKER;

ARTICLE; BEAN; BIOINFORMATICS; CELL MEMBRANE; CONFOCAL MICROSCOPY; CYTOPLASM; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MELANOMA; MELANOMA CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SERODIAGNOSIS; VICIA VILLOSA;

AMINO ACID SEQUENCE; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BLOTTING, WESTERN; CELL MEMBRANE; CELL NUCLEOLUS; COMPUTATIONAL BIOLOGY; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; GENES, MHC CLASS I; GLYCOPROTEINS; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; MASS SPECTROMETRY; MELANOMA; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PLANT LECTINS; RNA-BINDING PROTEINS; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 67649653719     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-009-0705-8     Document Type: Article

References (36)

1. S Aldi C Della Giovampaola R Focarelli A Armini M Ziche F Finetti F Rosati 2009 A fucose-containing O-glycoepitope on bovine and human nucleolin Glycobiology 19 337 343
2. J Bubenik 2005 MHC class I down-regulation, tumour escape from immune surveillance and design of therapeutic strategies Folia Biol (Praha) 51 1 2 (Pubitemid 40372914)
3. M Carpentier W Morelle B Coddeville A Pons M Masson J Mazurie D Legrand 2005 Nucleolin undergoes partial N- and O-glycosylations in the extracellular cell compartment Biochemistry 44 5804 5815 (Pubitemid 40525117)
4. C Chen S Chiang N Yeh 1991 Increased stability of nucleolin in proliferating cells by inhibition of its self-cleaving activity J Biol Chem 266 7754 7758 (Pubitemid 21906430)
5. S Christian J Pilch ME Akerman K Porkka P Laakkonen E Ruoslahti 2003 Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels J Cell Biol 163 871 878 (Pubitemid 37517893)
6. F Dall'Olio 1996 Protein glycosylation in cancer biology: an overview Clin Mol Pathol 49 126 135
7. J-S Deng B Ballou JK Hofmeister 1996 Internalization of anti-nucleolin antibody into viable HEp-2 cells Mol Biol Rep 23 191 195 (Pubitemid 27153041)
8. E Fonsatti AM Di Giacomo M Maio 2004 Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy? J Trans Med 2 21
9. H Ginisty H Sicard B Roger P Bouvet 1999 Structure and function of nucleolin J Cell Sci 112 761 772
10. A Glithero J Tormo JS Haurum G Arsequell G Valencia J Edwards S Springer A Townsend YL Pao M Wormald RA Dwek EY Jones T Elliott 1999 Crystal structures of two H-2Db/glycopeptides complexes suggest a molecular basis for CTL cross-reactivity Immunity 10 63 74 (Pubitemid 29077384)
11. S Hakomori 2002 Glycosylation defining cancer malignancy: new wine in an old bottle Proc Natl Acad Sci USA 99 10231 10233 (Pubitemid 34906955)
12. G Harms R Kraft G Grelle B Volz J Dernedde R Tauber 2001 Identification of nucleolin as a new L-selectin ligand Biochem J 360 531 538 (Pubitemid 34020257)
13. JS Haurum G Arsequell AC Lellouch SY Wong RA Dwek AJ McMichael T Elliott 1994 Recognition of carbohydrate by major histocompatibility comlex class I-restricted, glycopeptides-specific cytotoxic T lymphocytes J Exp Med 180 739 744
14. JS Haurum L Tan G Arsequell P Frodsham AC Lellouch PA Moss RA Dwek AJ McMichael T Elliott 1995 Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition Eur J Immunol 25 3270 3276 (Pubitemid 26004928)
15. JS Haurum IB Hoier G Arsequell A Neisig G Valencia J Zeuthen J Neefjes T Elliott 1999 Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo J Exp Med 190 145 150 (Pubitemid 29330132)
16. D Hoja-Łukowicz A Lityńska E Pocheć M Przybyło E Kremser D Ciołczyk-Wierzbicka P Laidler 2006 Identification of PNA-positive proteins in the primary uveal melanoma cell line by mass spectrometry Acta Biol Cracov Ser Zool 48 39 47
17. AG Hovanessian F Puvion-Dutilleul S Nisole J Svab E Perret JS Deng B Krust 2000 The cell-surface-expressed nucleolin is associated with the actin cytoskeleton Exp Cell Res 261 312 328 (Pubitemid 32010228)
18. Y Huang H Shi H Zhou X Song S Yuan Y Luo 2006 The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin Blood 107 3564 3571
19. EJ Joo GB ten Dam TH van Kuppevelt T Toida RJ Linhardt YS Kim 2005 Nucleolin: acharan sulfate-binding protein on the surface of cancer cells Glycobiology 15 1 9 (Pubitemid 40202034)
20. J Kanitakis I Al-Rifai M Faure A Claudy 1998 Differential expression of cancer associated antigen T (Thomsen-Friedenrich) and Tn to the skin in primary and metastatic carcinomas J Clin Pathol 51 588 592 (Pubitemid 28394250)
21. IB Kastrup S Stevanovic G Arsequell G Valencia J Zeuthen HG Rammensee T Elliot JS Haurum 2000 Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivo Tissue Antigens 56 129 135 (Pubitemid 30621278)
22. P Laidler A Lityńska D Hoja-Łukowicz M Łabȩ dź M Przybyło D Ciołczyk-Wierzbicka E Pocheć E Trȩbacz E Kremser 2006 Characterization of glycosylation and adherent properties of melanoma cell lines Cancer Immunol Immunother 55 112 118 (Pubitemid 41783301)
23. UK Laemmli 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 680 685
24. SK Lau JW Dennis 2008 N-glycans in cancer progression Glycobiology 18 750 760
25. D Legrand K Vigie EA Said E Elass M Masson MC Slomiany M Carpentier JP Briand J Mazurier AG Hovanessian 2004 Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells Eur J Biochem 271 303 317 (Pubitemid 38130458)
26. E Lisowska 2002 The role of glycosylation in protein antigenic properties CMLS, Cell Mol Life Sci 59 445 455 (Pubitemid 34267385)
27. B Monzavi-Karbassi P Luo F Jousheghany M Torres-Quinones G Cunto-Amesty C Artaud T Kieber-Emmos 2004 A mimic of tumor rejection antigen-associated carbohydrates mediates an antitumor cellular response Cancer Res 64 2162 2166 (Pubitemid 38339468)
28. N Renkvist C Castelli PF Robbins G Parmanini 2001 A listing of human tumor antigens recognized by T cells Cancer Immunol Immunother 50 3 15 (Pubitemid 32250041)
29. EA Said J Courty J Svab J Delbe B Krust AG Hovanessian 2005 Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin FASEB J 272 4646 4659 (Pubitemid 41366988)
30. R Salazar R Brandt J Kellermann S Krantz 2000 Purification and characterization of a 200 kDa fructosyllysine-specific binding protein from cell membranes of U937 cells Glycoconjugate J 17 713 716 (Pubitemid 32493949)
31. A Singhal M Fohn S Hakomori 1991 Induction of α-N- acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular response for active immunotherapy in mice Cancer Res 51 1406 1411
32. JA Speir UM Abde-Motal M Jondal IA Wilson 1999 Crystal structure of an MHC class I presented glycopeptides that generates carbohydrate-specific CTL Immunity 10 51 61 (Pubitemid 29077383)
33. GF Springer 1989 Tn epitope (N-acetyl-D-galactosamineα-O-serine/ threonine) density in primary breast carcinoma: a functional predictor of aggressiveness Mol Immunol 26 1 5 (Pubitemid 19024635)
34. M Srivastava HB Pollard 1999 Molecular dissection of nucleolin's role in growth and cell proliferation: new insights FASEB J 13 1911 1922 (Pubitemid 29517621)
35. A Thies I Moll J Berger U Schumacher 2001 Lectin binding to cutaneous malignant melanoma: HPA is associated with metastasis formation Br J Cancer 84 819 823 (Pubitemid 32275657)
36. LM Weiner MV Dhodapkar S Ferrone 2009 Monoclonal antibodies for cancer immunotherapy Lancet 373 1033 1040